Physician profile
Douglas A Swartz
NPI 1144361908
$117,506.73
in general payments reported to CMS, 2019-2025
37 companies · $4,196 in 2025
The $4,196 reported for 2025 was more than what 89% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $18K · 2021: $19K · 2022: $19K · 2023: $18K · 2024: $19K · 2025: $4,196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $38K · Food and Beverage: $2,738 · Education: $285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $38,372.00 |
| Food and Beverage | $2,737.81 |
| Education | $284.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Srs Medical Systems, INC. | $109,500.00 | 2019-2025 | Urocuff-Dc Disposable, Single, Ct3000 Pro Base Unit, Urocuff |
| Bayer Healthcare Pharmaceuticals INC. | $1,129.87 | 2020-2025 | |
| Blue Earth Diagnostics | $1,126.74 | 2021-2024 | |
| Karl Storz Endoscopy-America | $990.00 | 2019 | |
| Boston Scientific Corporation | $596.01 | 2019-2024 | Lumenis Pulse 120h, Moses 550 Dfl |
| Medtronic USA, INC. | $593.50 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $432.49 | 2025 | Adstiladrin |
| Teleflex LLC | $424.38 | 2022-2025 | Barrigel |
| Janssen Biotech, INC. | $421.55 | 2021-2025 | Erleada, Carvykti, Rybrevant |
| Pfizer INC. | $312.63 | 2019-2024 | |
| Dornier Medtech America, INC | $227.36 | 2025 | Dornier Medtech |
| Progenics Pharmaceuticals, INC. | $178.95 | 2024 | |
| Dendreon Pharmaceuticals LLC | $168.56 | 2022-2025 | Provenge |
| Astellas Pharma US INC | $161.25 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $130.50 | 2025 | Lynparza |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $119.98 | 2022-2025 | Jelmyto |
| Merck Sharp & Dohme LLC | $107.89 | 2022-2025 | Lynparza |
| Telix Pharmaceuticals | $107.50 | 2024 | Illuccix |
| Antares Pharma, INC. | $97.90 | 2019-2022 | |
| Tolmar Pharmaceuticals, INC. | $83.86 | 2022 | |
| Novartis Pharmaceuticals Corporation | $82.19 | 2022-2025 | |
| Calyxo, INC. | $79.63 | 2025 | Cvac Aspiration System |
| Angiodynamics, INC. | $71.13 | 2022-2025 | Nanoknife |
| Olympus America INC. | $48.84 | 2021-2025 | Bovie, Itind System |
| Rochester Medical Corporation | $46.77 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $45.63 | 2022-2024 | Oxlumo |
| Sumitomo Pharma America, INC. | $34.80 | 2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $30.50 | 2021-2025 | |
| Laborie Medical Technologies Corp. | $27.92 | 2024-2025 | Endosheath Technology, Optilume Bph Drug Coated Balloon Catheter |
| Allergan, INC. | $23.14 | 2021 | |
| Biotissue Holdings INC. | $23.07 | 2023 | |
| Tolmar, INC. | $20.69 | 2023 | |
| Agiliti Surgical, INC. | $14.64 | 2024 | Lasers |
| Innovation Technologies INC | $14.17 | 2025 | Irrisept |
| Aytu Biopharma, INC. | $13.12 | 2020 | |
| Myovant Sciences INC. | $11.70 | 2022 | |
| Aroa Biosurgery Incorporated | $7.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Swartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.